Specifically, there were quantitative differences between the expressions of IRS1, PIK3R1, SLC2A1, SLC2A3, and SLC2A4 among the patients with GDM during pregnancy and at 1-year postpartum, i.e., in the two studied groups differing in the degree of insulin resistance. This evidence concerns the gene IRS1 and Insulin resistance.